Agreement between different recall periods in drug utilization studies

Abstract

ABSTRACT:Objective: To assess the agreement between three recall periods for self-reported drug use using a 24-hour recall period as reference. Methods: Participants were allocated into three groups with different recall periods of 7, 14 and 30 days and were interviewed at two different times. A 24-hour recall questionnaire was answered during the first interview, and a questionnaire on drug use over the different recall periods tested was answered during the second interview. The agreement between the questionnaires was evaluated using percent agreement and kappa. Results: For continuous drugs, percent agreement varied between 92 and 99% and kappa varied between 0.71 and 0.97 for three periods tested. For drugs of occasional use, percent agreement varied between 63 and 81% and kappa varied between 0.27 and 0.52. The prevalence of drugs, particularly those of occasional use, increases with time. Conclusions: The high level of agreement between the three recall periods suggests that all of them are valid for the investigation of drugs of continuous use.

Use of drugs for gastrointestinal disorders: evidence from National Survey on Access, Use and Promotion of Rational Use of Medicines

“…Several authors have presented evidence that the knowledge of pharmacotherapy is associated with compliance, and consequently, there is a higher change of therapeutic success. (31)(32)(33)(34)(35) No studies were found evaluating the level of knowledge of the Brazilian population about the drugs. In this case, we point out the importance of performing nationwide studies that evaluate the knowledge of the population about pharmacotherapy, in order to direct strategies and public policies, with a view to therapeutic success.…”

“…This study has a few limitations inherent to the method used, such as the memory recall bias, since the information obtained was self-reported by the survey participants. Moraes et al, (35) evaluated the agreement between a survey done at two instances in various groups, in which the difference was the time interval between the first and the second interview. In the group with the 14-day interval, it was noted that the Kappa value was 0.37 for occasional use of drugs, which fits into the classification of the drugs studied in this investigation.…”

“…Vários autores apresentam evidências de que o conhecimento sobre a farmacoterapia está associado à sua adesão e, consequentemente, à maior chance de sucesso terapêutico. ( 31 - 35 ) Não foram encontrados estudos que avaliaram o nível de conhecimento da população brasileira acerca dos medicamentos. Nesse cenário, ressalta-se a importância da realização de estudos de abrangência nacionais, que avaliem o conhecimento da população sobre a farmacoterapia, a fim de nortear estratégias e políticas públicas, tendo em vista o sucesso terapêutico.…”

“…Este estudo possui algumas limitações inerentes ao método empregado, como o viés recordatório, já que as informações obtidas foram autorreferidas pelos participantes do inquérito. Moraes et al, ( 35 ) avaliaram a concordância entre um inquérito feito em dois momentos em vários grupos, cuja diferença era o intervalo de tempo entre a primeira entrevista e a segunda. No grupo com intervalo de 14 dias, observou-se valor de Kappa de 0,37 para medicamentos de uso ocasional, que se enquadra na classificação dos medicamentos estudados nesta pesquisa.…”

The Adjective Rating Scale for Withdrawal: Validation of its ability to assess severity of prescription opioid misuse

“…Face‐to‐face administration has been pointed out as a good way to detect possible underestimation or overestimation of the patient's responses and to clarify questions (Edwards, ). In addition, recent drug abuse is more likely to be reported in face‐to‐face surveys (Pridemore, Damphousse & Moore, ), which have shown good agreement with pharmacy records of continuous‐use medication (Moraes, Mengue & Pizzol, ).…”